TC | 
Stat | 
Stk | 
Ins | 
Fil | 
+d | 
+w | 
+m | 
+q | 
+h | 
+y | 
avg | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 5 | -1 | 7 | -4 | -42 | -90 | -90 | -37 | 
| S | %wins | 40 | 60 | 40 | 80 | 100 | 100 | 70 | 
Filing Date | 
					T Date | 
					Ticker | 
					Issuer | Inc | 					Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/3/15 16:09  | 4/1/15  | CLDN | Celladon Corp | DE | Health | BioPrd | Biological Products, (No Diag | Takeya Ryan K | CA | O | VP,Manuf | S.d | -85 | 19.13 | 33 | -4 | -76 | 1 | D | 60 | 79 | -9 | 9 | -34 | -28 | -18 | 3 | -3 | -86 | -93 | -95 | ||
3/3/15 21:13  | 3/2/15  | CLDN | Celladon Corp | DE | Health | BioPrd | Biological Products, (No Diag | Takeya Ryan K | CA | O | VP,Manuf | S.d | -144 | 18.48 | 6 | -8 | -84 | 1 | D | 67 | 61 | 51 | 5 | 21 | 16 | 6 | 4 | 32 | 1 | -87 | -93 | ||
2/3/15 18:21  | 2/2/15  | CLDN | Celladon Corp | DE | Health | BioPrd | Biological Products, (No Diag | Takeya Ryan K | CA | O | VP,Manuf | S.d | -127 | 16.35 | 4 | -8 | -84 | 1 | D | 99 | 33 | 57 | -9 | -8 | 3 | -3 | -2 | -2 | 21 | -80 | -88 | ||
1/5/15 20:44  | 1/2/15  | CLDN | Celladon Corp | DE | Health | BioPrd | Biological Products, (No Diag | Takeya Ryan K | CA | O | VP,Manuf | S.d | -155 | 19.88 | 6 | -8 | -84 | 1 | D | 24 | 96 | 72 | 22 | 11 | -2 | -12 | -4 | -16 | -8 | -89 | |||
12/2/14 19:01  | 12/1/14  | CLDN | Celladon Corp | DE | Health | BioPrd | Biological Products, (No Diag | Takeya Ryan K | CA | O | VP,Manuf | S.d | -93 | 12.01 | 1 | -8 | -93 | 1 | D | 51 | 5 | 22 | 3 | 2 | -2 | 3 | 11 | 59 | 60 | -86 | -90 | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |